advertisement
 

  Back to Current Daily Care News Daily Care News from 2008

Daily Care News from 2008

    31 December 2008

  1. A Comparison of Glycemic Variability Associated With Insulin Glargine and Intermediate-Acting Insulin When Used as the Basal Component of Multiple Daily Injections for Adolescents With Type 1 Diabetes.
  2. Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus.
  3. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial.
  4. Glycaemic profile characteristics and frequency of impaired awareness of hypoglycaemia in subjects with T1D and repeated hypoglycaemic events.
  5. Adolescents' and mothers' perceptions of the cognitive and relational functions of collaboration and adjustment in dealing with type 1 diabetes.
  6. Collaborative Involvement of Primary and Secondary Caregivers: Associations with Youths' Diabetes Outcomes.
  7. Health Related Quality of Life of Children and Adolescents with Type 1 Diabetes.
  8. Metabolic acidosis in a patient with type 1 diabetes mellitus complicated by methanol and amitriptyline intoxication.
  9. Reversal of Type 2 Diabetes Mellitus and Improvements in Cardiovascular Risk Factors After Surgical Weight Loss in Adolescents. See also Type 2 Diabetes Reversed after Weight Loss Surgery in Adolescents.

    24 December 2008

  10. Insulin aspart in diabetic pregnancy: state of the art.
  11. The role of free-play physical activity in healthy blood glucose maintenance in children with type 1 diabetes mellitus.
  12. Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers.
  13. Lipid and Lipoprotein Profiles in Youth with and Without Type 1 Diabetes: The SEARCH Case-Control Study.
  14. The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes: a pilot study.
  15. Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetes.
  16. New Potential Adjuncts to Treatment of Children with Type 1 Diabetes Mellitus.
  17. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials (PDF).
  18. Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes.
  19. Diabetic retinopathy during pregnancy.
  20. Insulin immunoassays in the detection of insulin analogues in factitious hypoglycemia.
  21. Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum, Turkey.
  22. The utility and recent advances in self-monitoring of blood glucose in type 1 diabetes.

    17 December 2008

  23. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory.
  24. Glycemic index, postprandial glycemia, and the shape of the curve in healthy subjects: analysis of a database of more than 1000 foods.
  25. Rapid weight gain in children soon after diagnosis of type 1 diabetes: is there room for concern?
  26. Children With Diabetes At Increased Risk For Developing Eating Disorders.
  27. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.
  28. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
  29. Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes.
  30. Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes. Free full text available in HTML and PDF formats. See also Low-Sugar Diet Better for Glycemic Control Than High Intake of Cereal Fiber.

    10 December 2008

  31. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
  32. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
  33. Bolus calculator: a review of four "smart" insulin pumps.
  34. Management of diabetic ketoacidosis in children and adolescents.
  35. Clinical effectiveness of a brief educational intervention in Type 1 diabetes: results from the BITES (Brief Intervention in Type 1 diabetes, Education for Self-efficacy) trial.
  36. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial.
  37. Comparison of maternal ghrelin and leptin in healthy mothers and mothers with Type 1 diabetes.

    3 December 2008

  38. Canine Responses to Hypoglycemia in Patients with Type 1 Diabetes.
  39. Association Between the Dietary Approaches to Hypertension Diet and Hypertension in Youth With Diabetes Mellitus. See also Your Guide to Lowering Your Blood Pressure with DASH (PDF).
  40. Puberty and Ovarian Function in Girls with Type 1 Diabetes Mellitus.

    26 November 2008

  41. Insulin requirement in preschoolers treated with insulin pumps at the onset of type 1 diabetes mellitus.
  42. Feasibility of 10-Day Use of a Continuous Glucose Monitoring System in Adults with Type 1 Diabetes.
  43. Resolution of periodontal inflammation does not guarantee improved glycemic control in type 1 diabetic subjects.
  44. Weight-Loss Practices and Weight-Related Issues Among Youth With Type 1 or Type 2 Diabetes.
  45. Use of hormonal contraceptive methods by women with diabetes.
  46. Night/day ratio as predictor of preeclampsia in normoalbuminuric, diabetic women: early signs of blood pressure disorders.

    19 November 2008

  47. Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth with TIDM on Insulin Pump Therapy.
  48. Pramlintide in the treatment of diabetes mellitus.
  49. Intensity of immunity in children with type 1 diabetes mellitus vaccinated against hepatitis B.
  50. Psychological Therapy to Improve Control of Type 1 Diabetes.
  51. Web-based Collaborative Care for Type 2 Diabetes: a Pilot Randomized Trial.

    12 November 2008

  52. Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study.
  53. Used of oral antidiabetic agents in pediatric patients - own observations.
  54. Glycaemic control and diabetes care utilization in young adults with Type 1 diabetes.
  55. Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population.
  56. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes-the 'dead in bed' syndrome revisited.
  57. Parenting, autonomy and self-care of adolescents with Type 1 diabetes.
  58. Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control. Free full text available in HTML and PDF formats.
  59. Self-perceived oral health and salivary proteins in children with type 1 diabetes.
  60. Glycemia and cardiovascular disease in type 1 diabetes mellitus.
  61. Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: Impact on thyroid function, metabolic control and pregnancy outcome.

    5 November 2008

  62. Insulin Glargine versus Neutral Protamine Hagedorn Insulin for Treatment of Diabetes in Pregnancy.
  63. Starvation-induced True Diabetic Euglycemic Ketoacidosis in Severe Depression.
  64. Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
  65. Blood Glucose Monitoring is Associated with Better Glycemic Control in Type 2 Diabetes: A Database Study.

    29 October 2008

  66. Duration of Nocturnal Hypoglycemia Before Seizures.
  67. A comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal–bolus therapy for type 1 diabetes: the ADAPTTM Study.
  68. Continuous glucose monitoring: A review of biochemical perspectives and clinical use in type 1 diabetes.
  69. Improved Pregnancy Outcome In Type 1 Diabetic Women With Microalbuminuria Or Diabetic Nephropathy – Effect Of Intensified Antihypertensive Therapy?

    22 October 2008

  70. Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. Free full text available in HTML and PDF formats.
  71. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. Free full text available in HTML and PDF formats.
  72. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study. Free full text available in HTML and PDF formats.
  73. Equivalence of earlobe site blood glucose testing with finger stick.
  74. Quality of life of children and adolescents with diabetes of Northern Greek origin. Free full text available in HTML and PDF formats.
  75. Cataract and type 1 diabetes mellitus.
  76. Low density lipoprotein subclass distribution in children with diabetes mellitus.
  77. Designing mobile dietary management support technologies for people with diabetes.
  78. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire.
  79. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
  80. When Will We Treat Physical Activity as a Legitimate Medical Therapy......even though it does not come in a pill?

    15 October 2008

  81. A Study Assessing an Injection Port for Administration of Insulin.
  82. Case Study: Successful Use of a Single Subcutaneous Continuous Glucose Monitor Sensor for 28 Days in a Patient with Type 1 Diabetes. Also available in PDF format.
  83. Identity development, coping, and adjustment in emerging adults with a chronic illness: the sample case of type 1 diabetes.
  84. Targeting blood glucose management in school improves glycemic control in children with poorly controlled type 1 diabetes mellitus.
  85. Deleterious outcomes after abrupt transition from insulin glargine to insulin detemir in patients with type 1 diabetes mellitus.
  86. Cardiometabolic risk and educational level in adult patients with type 1 diabetes.

    8 October 2008

  87. The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes.
  88. Characteristics of adolescents with type 1 diabetes who exhibit adverse outcomes.
  89. Teacher support of adherence for adolescents with type 1 diabetes: preferred teacher support behaviors and youths' perceptions of support.
  90. Out-patient determination of glycosylated haemoglobin in the monitoring and control of diabetes mellitus: systematic review of the literature.
  91. Ethnic differences in outcomes of diabetes care and the role of self-management behavior.
  92. Clinical usefulness of a bolus calculator in maintaining normoglycaemia in active professional patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
  93. Effects of the Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Individuals with T1DM.
  94. The effect of parental type 2 diabetes on the offspring with type 1 diabetes.
  95. Dispersion of the P wave as a test for cardiac autonomic function in diabetic children.
  96. Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes.
  97. Improvements in glycaemic control and cardiovascular risk factors in a cohort of patients with type 1 diabetes over a 5-year period.
  98. Differential effects of two different isoenergetic meals one rich in saturated and one rich in monounsaturated fat on endothelial function in subjects with type 2 diabetes mellitus.

    1 October 2008

  99. Responsive parenting is associated with improved type 1 diabetes-related quality of life.
  100. Children's views of their adaptation to type 1 diabetes mellitus.
  101. Smoking and Metabolic Control in Adolescents with Type 1 Diabetes.
  102. Weight-Loss Practices and Weight-Related Issues among Youth with Type 1 or Type 2 Diabetes.
  103. Safety of new algorithms for premeal insulin boluses in high glycaemic index meals in persons with type 1 diabetes mellitus using insulin pumps. Free full text available in PDF format.
  104. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Free full text available in HTML and PDF formats.
  105. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

    21 September 2008

  106. Blood pressure may predict retinopathy in adolescent type 1 diabetes.
  107. DAWN Youth survey results released. See also the Press Release on DAWN Youth, which notes that "Nine out of 10 children with diabetes lack support at school."
  108. On Caring For 'Difficult' Patients includes "Willy: Refusing Recommendations And Calling The Shots," about an adult with type 1 diabetes.

    20 September 2008

  109. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. Free full text available in HTML and PDF formats. See also Continuous Glucose Monitoring Improves Blood Sugar Control, Clinical Trial Demonstrates, Under-the-Skin Blood Sugar Monitor Boosts Diabetes Control, and Adult Diabetics Benefit From Device, Study Says.
  110. The full text of Real-Time Glucose Sensors in Children and Adolescents with Type-1 Diabetes, previously reported, is now available in HTML and PDF formats.
  111. Evaluation of a continuous glucose monitoring system for home-use conditions.
  112. Long-term improvement of fasting glycaemia after switching basal insulin from NPH to determir in children with type 1 diabetes: a 1-year multicentre study.
  113. Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. See also CareLink™ Personal Software at the Medtronic Diabetes web site.
  114. Sweets, snacking habits, and skipping meals in children and adolescents on intensive insulin treatment.
  115. Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes.
  116. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents.
  117. The impact of modifiable family factors on glycemic control among youth with type 1 diabetes.
  118. Does family cohesiveness and parental alexithymia predict glycaemic control in children and adolescents with diabetes?
  119. The Influence of Caregiver Depressive Symptoms on Proxy Report of Youth Depressive Symptoms: A Test of the Depression-Distortion Hypothesis in Pediatric Type 1 Diabetes.
  120. Prevalence of overweight and obesity in children and adolescents with type 1 diabetes mellitus.
  121. Diabetes and the vitamin d connection.
  122. Insulin allergy desensitization with simultaneous intravenous insulin and continuous subcutaneous insulin infusion.
  123. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. Free full text available in HTML and PDF formats. See also Intense diabetes treatment pays off in long run; Study: Tight blood sugar control after diagnosis drives big benefits later.

    7 September 2008

  124. Real-Time Glucose Sensors in Children and Adolescents with Type-1 Diabetes.
  125. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial.
  126. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
  127. Physical activity and overweight in children and adolescents using intensified insulin treatment.
  128. Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial.
  129. Cognitive Function in Children With Type 1 Diabetes.
  130. Belonging to a diabetes patients' association is predictive of better metabolic control.
  131. Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes.
  132. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials.
  133. Assessment of risk factors of poor metabolic control in type 1 diabetic children assisted in a public hospital in Argentina.
  134. Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes.
  135. Dental Caries Increments and Related Factors in Children with Type 1 Diabetes Mellitus.
  136. Special needs of children with type 1 diabetes at primary school: perceptions from parents, children, and teachers.
  137. Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes.
  138. Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered? Free full text available in HTML and PDF formats.
  139. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
  140. Impact of White-coat Hypertension on Microvascular Complications in Type 2 Diabetes Mellitus.
  141. Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity.

    7 September 2008

  142. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. Free full text available in HTML and PDF formats.
  143. A Medical Home for Children With Insulin-Dependent Diabetes: Comanagement by Primary and Subspecialty Physicians—Convergence and Divergence of Opinions. Free full text available in HTML and PDF formats.

    24 August 2008

  144. Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study.
  145. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes.
  146. Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
  147. Improved Glycemic Control in Intensively Treated Adult Subjects with Type 1 Diabetes Using Insulin Guidance Software.
  148. Effects of acute insulin-induced hypoglycaemia on psychomotor function: people with type 1 diabetes are less affected than non-diabetic adults.
  149. Effect of Insulin with Oral Nutrients on Whole-body Protein Metabolism in Growing Pubertal Children with Type 1 Diabetes.
  150. Sprint training increases muscle oxidative metabolism during high-intensity exercise in patients with type 1 diabetes.
  151. A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes. Free full text available in HTML and PDF formats.
  152. Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus.
  153. Diabetes problem solving by youths with type 1 diabetes and their caregivers: measurement, validation, and longitudinal associations with glycemic control. Free full text available in HTML and PDF formats.
  154. Long-term adherence to statin treatment in diabetes.
  155. Diagnosed diabetic retinopathy in France, Italy, Spain, and the United Kingdom.

    17 August 2008

  156. Duration of Nocturnal Hypoglycemia Prior to Seizures.
  157. Impact of family environment and support on adherence, metabolic control, and quality of life in adolescents with diabetes.
  158. Free full text for Differences in Family Mealtime Interactions between Young Children with Type 1 Diabetes and Controls: Implications for Behavioral Intervention, previously reported, is now available in HTML and PDF formats.
  159. People with type 1 diabetes using short acting analogue insulins are less dehydrated than those with using human soluble insulin prior to onset of diabetic ketoacidosis.
  160. New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.
  161. Parental anxiety and depression associated with caring for a child newly diagnosed with type 1 diabetes: Opportunities for education and counseling.
  162. Restoration of Hypoglycemia Awareness after Islet Transplantation.
  163. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery.

    10 August 2008

  164. Victimization of youth with type-1 diabetes by teachers: relations with adherence and metabolic control.
  165. Barriers to physical activity among patients with type 1 diabetes.
  166. Disturbed eating behaviors in Taiwanese adolescents with type 1 diabetes mellitus: a comparative study.
  167. Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes.
  168. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.
  169. An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update).
  170. Sudden death in type 1 diabetes: The mystery of the 'dead in bed' syndrome.
  171. Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia.
  172. Short-term mortality risk in children and young adults with type 1 diabetes: The population-based Registry of the Province of Turin, Italy.
  173. Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study.
  174. Pilot study of a novel education programme for 11-16 year olds with Type 1 Diabetes Mellitus: the KICk-OFF course.
  175. Perceived diabetes status is independently associated with glucose monitoring behaviour among type 2 diabetes mellitus patients.

    3 August 2008

  176. Patients' engagement with "Sweet Talk" - a text messaging support system for young people with diabetes. Free full text available in HTML format.
  177. Switching of NPH insulin to glargine therapy in a cohort of diabetic patients: observational study. Free Portuguese language full text available in HTML and PDF formats.
  178. Assessment of an Illness-specific Dimension of Self-esteem in Youths with Type 1 Diabetes.
  179. Type 1 diabetes in children and adolescents--new strategies in management and treatment.
  180. Pharmacist screening for depression among patients with diabetes in an urban primary care setting.
  181. Evidence-based emergency medicine/critically appraised topic. Is fluid therapy associated with cerebral edema in children with diabetic ketoacidosis?

    27 July 2008

  182. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
  183. Dosing accuracy of two insulin pre-filled pens.
  184. Antibody response to insulin in children and adolescents with newly diagnosed Type 1 diabetes.
  185. HbA1c variability and the risk of microvascular complications in type 1 diabetes: data from the DCCT.
  186. Insulin administration and rate of glucose appearance in people with type 1 diabetes.
  187. Ketoacidosis occurs in both Type 1 and Type 2 diabetes- a population-based study from Northern Sweden.
  188. Diabetic retinopathy at high altitude.

    20 July 2008

  189. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study.
  190. Intermediate acting versus long acting insulin for type 1 diabetes mellitus.
  191. Mothers', Fathers', and Children's Perceptions of Parental Diabetes Responsibility in Adolescence: Examining the Roles of Age, Pubertal Status, and Efficacy.
  192. International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life.
  193. Neuro-cognitive Performance in Children with Type 1 Diabetes--A Meta-analysis.
  194. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections. (Click "English" link to read in English.) Free full text available in PDF format.
  195. The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes.
  196. Prediction of the Onset of Disturbed Eating Behavior in Adolescent Girls with Type 1 Diabetes.
  197. Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet. Free full text available in PDF format.

    13 July 2008

  198. The Impact of Diabetes and its Treatment on Cognitive Function among Adolescents Who Participated in the DCCT.
  199. Health-Related Quality of Life of Children and Adolescents With Type 1 or Type 2 Diabetes Mellitus.
  200. Glycemic control and the psychosocial benefits gained by patients with type 1 diabetes mellitus attending the diabetes camp.
  201. Lipid Screening and Cardiovascular Health in Childhood. Free full text available in HTML and PDF formats. See also AAP Revises Cholesterol Screening Guidelines for Children.
  202. A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes.
  203. New therapeutic approaches to diabetic gastroparesis.
  204. Rosiglitazone and delayed onset of proliferative diabetic retinopathy.

    6 July 2008

  205. Insulin Glargine Versus Intermediate-Acting Insulin as the Basal Component of Multiple Daily Injection Regimens for Adolescents with Type 1 Diabetes Mellitus.
  206. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.
  207. Young Women with Type 1 Diabetes Have Lower Bone Mineral Density That Persists Over Time.
  208. Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People.
  209. Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants.
  210. Randomized Efficacy Trial of Early Preconception Counseling for Diabetic Teens (READY-Girls).

    29 June 2008

  211. The influence of type-1 diabetes mellitus on dentition and oral health in children and adolescents. Free full text available in PDF format.
  212. The impact of type 1 diabetes and eating disorders: the perspective of individuals.
  213. Predictors of Diabetes-related Quality of Life after Transitioning to the Insulin Pump.
  214. Cardiometabolic goal attainment during regular care of adult patients with type 1 diabetes mellitus.
  215. Isolation, motivation and balance: living with type 1 or cystic fibrosis-related diabetes.
  216. Difficulties or mistakes in diagnosing type 1 diabetes mellitus in children? The consequences of delayed diagnosis.
  217. Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis.
  218. Inaccurate hemoglobin A(1C) levels in patients with type 1 diabetes and hereditary persistence of hemoglobin F.
  219. Patient's opinion on the barriers to diabetes control in areas of conflicts. The Iraqi example. Free full text available in PDF format.

    22 June 2008

  220. Available tools for primary ketoacidosis prevention at diabetes diagnosis in children and adolescents. "The Parma campaign". Free full text available in PDF format.
  221. Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint. Free full text available in PDF format.
  222. Delayed diagnosis in Type 1 diabetes mellitus.
  223. MST for Adolescents with Poorly Controlled Type I Diabetes: Reduced DKA Admissions and Related Costs over 24 Months.
  224. Menarcheal timing in intensively treated girls with type 1 diabetes mellitus.
  225. Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk..
  226. Causes of death in young Australians with type 1 diabetes: a review of coronial postmortem examinations. Free full text available in HTML and PDF formats (free registration required).
  227. Plasma carotenoids and diabetic retinopathy.
  228. ENDO: Diabetes Drug Puts Puberty in Its Place.

    15 June 2008

  229. Medpage Today coverage of the 2008 ADA meeting includes:
    1. Estimated Average Glucose: Its Meaning for Patient Care.
    2. Pramlintide May Be Better Choice than Insulin as Mealtime Diabetes Add-on Drug.
    3. No Change in Clinical Practice After Intensive Glucose Management Fails in Trials.
  230. School-age children with diabetes: role of maternal self-efficacy, environment, and management behaviors.
  231. Short-term effects of coping skills training in school-age children with type 1 diabetes.
  232. Periodontal Disease in Children and Adolescents With Type 1 Diabetes in Serbia.
  233. Severe insulin resistance secondary to insulin antibodies: successful treatment with the immunosuppressant MMF.
  234. Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetes.
  235. Effects of Intensive Glucose Lowering in Type 2 Diabetes: The Action to Control Cardiovascular Risk in Diabetes Study Group. Free full text available in HTML and PDF formats.
  236. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes: The ADVANCE Collaborative Group. Free full text available in HTML and PDF formats.
  237. Intensive Glycemic Control in the ACCORD and ADVANCE Trials offers analysis of these two recently reported trials. Free full text available in PDF format.

    8 June 2008

  238. Translating the A1C Assay Into Estimated Average Glucose Values. Free full text available in PDF format. See also Translating The Hemoglobin A1c Assay (PDF) and Formula Puts Doctor, Patient Glucose Readings on Same Page.
  239. Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children. Free full text available in HTML and PDF formats.
  240. School nurses' perceived barriers to diabetes knowledge, communication and management in children with type 1 diabetes.
  241. Exenatide: Its position in the treatment of type 2 diabetes.

    1 June 2008

  242. Getting closer to physiologic insulin secretion.
  243. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
  244. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
  245. Optimizing postprandial glycemia in pediatric patients with Type 1 diabetes using insulin pump therapy – impact of glycemic index and prandial bolus type.
  246. The June 2008 issue of Diabetes Technology & Therapeutics focuses on glucose monitoring, with free full text available for all articles. Selected articles include:

    1. Glucose Monitoring: An Important Tool for Improving Glucose Control and Reducing Hypoglycemia. Free full text available in PDF format.
    2. The Technology Behind Glucose Meters: Test Strips. Free full text available in PDF format.
    3. Clinical Application and Challenges of Blood Glucose Measurement Technology for Self-Monitoring. Free full text available in PDF format.
    4. The Utility and Recent Advances in Self-Monitoring of Blood Glucose in Type 1 Diabetes. Free full text available in PDF format.
  247. Maternal type 1 and gestational diabetes: postnatal differences in insulin secretion in offspring at preschool age.
  248. Interference of the blood glucose control in the transition between phases I and II of lactogenesis in patients with type 1 diabetes mellitus.
  249. Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomes.
  250. Monitoring and Discussing Health Related Quality of Life in adolescents with type 1 diabetes improves psychosocial well-being. A randomized controlled trial.
  251. Diabetes Complications in Youth: Qualitative Analysis of Parents' Perspectives of Family Learning and Knowledge.
  252. 'Dead-in-bed' syndrome - a diabetes nightmare.
  253. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
  254. Adherence to Mediterranean diet and risk of developing [type 2] diabetes: prospective cohort study. Free full text available in HTML and PDF formats.

    25 May 2008

  255. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.
  256. Insulin Binding to Antibodies is a Risk Factor for Inexplicable Severe Hypoglycaemia in Children with Type-1 Diabetes Mellitus.
  257. Intensive insulin therapy in preschool-aged diabetic children: from multiple daily injections to continuous subcutaneous insulin infusion through indwelling catheters.
  258. The Use of Insulin Pump Therapy in the Pediatric Age Group.
  259. Insulin Glargine Maintains Equivalent Glycemic Control and Better Lipometabolic Control than NPH Insulin in Type 1 Diabetes Patients Who Missed a Meal.
  260. Breastfeeding and risk of becoming overweight in offspring of mothers with type 1 diabetes.
  261. Association of numeracy and diabetes control.

    18 May 2008

  262. Real-time continuous glucose monitoring together with telemedical assistance improves glycemic control and glucose stability in pump-treated patients.
  263. Brief Report: The Relationship of Parental Support and Conflict to Physical Activity in Preadolescents with Type 1 Diabetes.
  264. Blood Glucose Awareness Training Delivered Over the Internet.
  265. Treatment of Danish adolescent diabetic patients with CSII - a matched study to MDI.

    11 May 2008

  266. Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison.
  267. Disordered eating and body dissatisfaction in adolescents with type 1 diabetes and a population-based comparison sample: comparative prevalence and clinical implications.
  268. Insulin Analog Preparations and Their Use in Children and Adolescents with Type 1 Diabetes Mellitus.
  269. The influence of and optimal insulin therapy for a low glycemic index meal in children with type one diabetes on intensive insulin therapy.
  270. The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial.
  271. Sibling psychological adjustment to type 1 diabetes mellitus.
  272. Thyroid autoimmunity in children with features of both type 1 and type 2 diabetes.
  273. Prevalence of Autoimmune Thyroid Disease and Thyroid Dysfunction in Young Brazilian Patients with Type 1 Diabetes.
  274. Evolution of bone mass in children and adolescents with type 1 diabetes mellitus.
  275. Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group.
  276. Metformin versus Insulin for the Treatment of Gestational Diabetes.

    4 May 2008

  277. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
  278. Respiratory infection recurrence and passive smoking in early atherosclerosis in children and adolescents with type 1 diabetes.
  279. Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized.
  280. Presence of Diabetic Ketoacidosis at Diagnosis of Diabetes Mellitus in Youth: The Search for Diabetes in Youth Study. Free full text available in HTML and PDF formats.
  281. Adolescent Use of Insulin and Patient-Controlled Analgesia Pump Technology: A 10-Year Food and Drug Administration Retrospective Study of Adverse Events. Free full text available in HTML and PDF formats.
  282. Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus.
  283. The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus.
  284. Assessment of main metabolic substrates utilization during aerobic phase of physical exercises in patients with first diagnosed type 1 diabetes mellitus and in healthy persons.
  285. Gas exchange function of the lungs in patients with type 1 diabetes mellitus.
  286. Accelerated Tooth Eruption in Children With Diabetes Mellitus. Free full text available in HTML and PDF formats.
  287. Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus? Free Portuguese language full text available in HTML and PDF formats.
  288. Routine glutamic acid decarboxylase autoantibody (GADA) testing: patients' perspective.
  289. The risks of non-traumatic lower extremity amputations in patients with type 1 diabetes – a population-based cohort study in Sweden.
  290. Preventing Left Ventricular Hypertrophy By Ace Inhibition In Hypertensive Patients With Type 2 Diabetes: A Prespecified Analysis Of The BENEDICT Trial.
  291. Cost-effectiveness of Intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the steno-2 study.

    27 April 2008

  292. The Relationship between Negative Communication and Body Image Dissatisfaction in Adolescent Females with Type 1 Diabetes Mellitus.
  293. Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark.
  294. Road traffic accidents and diabetes: insulin use does not determine risk.
  295. Randomized Efficacy Trial of Early Preconception Counseling for Diabetic Teens (READY-Girls).
  296. Flexible, intensive insulin therapy and dietary freedom in adolescents and young adults with Type 1 diabetes: a prospective implementation study.
  297. Upper abdominal symptoms in patients with Type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy.
  298. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes.
  299. Varenicline may trigger severe hypoglycaemia in Type 1 diabetes.
  300. GLP-1: physiological effects and potential therapeutic applications.

    20 April 2008

  301. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. Free full text available in HTML and PDF formats. See also 500,000 'making themselves depressed by unecessary blood sugar self-tests,' new study claims.
  302. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2). Free full text available in PDF format.
  303. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents.
  304. Elevated third-trimester haemoglobin A(1c) predicts preterm delivery in type 1 diabetes.
  305. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study.
  306. Training tomorrow's doctors in diabetes: self-reported confidence levels, practice and perceived training needs of post-graduate trainee doctors in the UK: a multi-centre survey. Free full text available in PDF format.
  307. Shortage of pediatric endocrinologists found.

    13 April 2008

  308. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.
  309. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes.
  310. Dietary Behaviors Predict Glycemic Control In Youth With Type 1 Diabetes.
  311. Teaching children with diabetes about adequate dietary choices.
  312. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics.
  313. Parent-adolescent communication and diabetes: an integrative review.
  314. Albumin Excretion Rate in Normal Adolescents: Relation to Insulin Resistance and Cardiovascular Risk Factors and Comparisons to Type 1 Diabetes Mellitus Patients.
  315. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
  316. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.
  317. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes.
  318. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. Free full text available in PDF format.
  319. Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study. See also Egg Consumption Poses Risks for Diabetic Men: Study.
  320. Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk. A Population Study of 3.3 Million People.

    6 April 2008

  321. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.
  322. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes.
  323. Poor Glycemic Control Linked to Development of Microalbuminuria in Type 1 Diabetes. Note: CME credit is offered to physicians for answering questions related to this paper. Free Medscape registration is required.
  324. Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes?
  325. Altered endothelial function in asymptomatic male adolescents with type 1 diabetes.
  326. Long-term prevention of diabetic nephropathy: an audit.
  327. Continuous Subcutaneous Glucose Monitoring System in diabetic mothers during labour and postnatal glucose adaptation of their infants.
  328. Adjust To Target In Type 2 Diabetes: Comparison Of A Simple Algorithm To Carbohydrate Counting For Adjustment Of Mealtime Insulin Glulisine.

    30 March 2008

  329. Evaluation of treatment satisfaction associated with the use of insulin aspart in continuous subcutaneous insulin infusion.
  330. Continuous insulin infusion (CSII) or modern type of multiple daily injections (MDI) in diabetic children and adolescents a critical review on a controversial issue.
  331. Differences in Family Mealtime Interactions between Young Children with Type 1 Diabetes and Controls: Implications for Behavioral Intervention.
  332. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.
  333. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes.
  334. Providing Diabetes Care to Arab Migrants in the UK: Cultural and Clinical Aspects.
  335. Adjust To Target In Type 2 Diabetes: Comparison Of A Simple Algorithm To Carbohydrate Counting For Adjustment Of Mealtime Insulin Glulisine.
  336. Improvements in HbA1c remain after 5 years - a follow up of an educational intervention focusing on patients' personal understandings of type 2 diabetes.
  337. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports.

    23 March 2008

  338. Experiences of parents of young people with diabetes using insulin pump therapy.
  339. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
  340. Impaired endothelial function in adolescents with type 1 diabetes mellitus.
  341. Varenicline may trigger severe hypoglycaemia in Type 1 diabetes.
  342. Reproductive History and Hormonal Birth Control Use are Associated with Coronary Calcium Progression in Women with Type 1 Diabetes Mellitus. Free full text available in PDF format.
  343. Cure or control: complying with biomedical regime of diabetes in Cameroon. Free full text available in HTML and PDF formats.
  344. Characteristics of men and women with diabetes; Observations during patients' initial visit to a diabetes education centre. Free full text available in HTML and PDF formats.

    16 March 2008

  345. Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring?
  346. Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control.
  347. Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in people with Type 1 diabetes.
  348. Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.
  349. Comparison Of The Numerical And Clinical Accuracy Of Four Continuous Glucose Monitors.
  350. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry.
  351. Progression of retinopathy in type 1 diabetic women during pregnancy.
  352. Use of complementary and alternative medicine in children with type 1 diabetes mellitus - prevalence, patterns of use, and costs.
  353. Physical work ability in patients with type 1 diabetes.
  354. Low levels of parental monitoring affected adolescents' HbA1c; Fathers' monitoring had an independent effect on their children's HbA1c levels. See also The Role of Parental Monitoring in Understanding the Benefits of Parental Acceptance on Adolescent Adherence and Metabolic Control of Type 1 Diabetes, previous reported.
  355. Fathers of children and adolescents with diabetes: what do we know?
  356. Racial Disparities in Diabetes Mortality Among Persons Aged 1-19 Years—United States, 1979-2004.

    9 March 2008

  357. Sensor-augmented pump therapy in type 1 diabetes.
  358. Detection of Hypoglycemia by Children With Type 1 Diabetes 6 to 11 Years of Age and Their Parents: A Field Study.
  359. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE(TM) study.
  360. Thyroid function and anti-thyroid antibodies in Iranian patients with type 1 diabetes mellitus: influences of age and sex.
  361. Becoming pregnant: exploring the perspectives of women living with diabetes.
  362. Empowered to change: evidence from a qualitative exploration of a user-informed psycho-educational programme for people with type 1 diabetes.
  363. Meta-analysis of Health Behavior Change Interventions in Type 1 Diabetes.
  364. Hospitalization for vascular complications in childhood onset type 1 diabetes - effects of gender and age at onset.
  365. The influence of chronic diabetes mellitus on the thickness and the shape of the anterior and posterior surface of the cornea.
  366. The impact of diabetes on prescription drug costs: the population-based Turin study.

    2 March 2008

  367. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
  368. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
  369. Relationship of A1C to Glucose Concentrations in Children With Type 1 Diabetes - Assessments by high-frequency glucose determinations by sensors.
  370. A Brief Report entitled FreeStyle Navigator Continuous Glucose Monitoring System Use in Children With Type 1 Diabetes Using Glargine-Based Multiple Daily Dose Regimens from the DirecNet groups showed that kids using MDI instead of pump therapy also benefited from the use of a continuous glucose sensor.
  371. A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes. Free full text available in HTML and PDF formats.
  372. Glycaemic control and body mass index in late-adolescents and young adults with Type 1 diabetes mellitus: a population-based study.
  373. Altered Neuroendocrine Sleep Architecture in Patients with Type 1 Diabetes.
  374. Insulin Restriction and Associated Morbidity and Mortality in Women with Type 1 Diabetes. See also Joslin Study Finds Restricting Insulin Doses Increases Mortality Risk and Study: Risk deadly for diabetic women who restrict insulin.
  375. Human Insulin Analog–Induced Lipoatrophy.
  376. Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes?
  377. Glycemic Control in Youth with Type 1 Diabetes: Family Predictors and Mediators.
  378. Factors Affecting Use of Insulin Pens by Patients With Type 2 Diabetes.
  379. Using meal-based self-monitoring of blood glucose as a tool to improve outcomes in pregnancy complicated by diabetes.
  380. Intensive insulin therapy and mortality in critically ill patients. See also Intensive Insulin Therapy in ICU Lacks Real-World Benefit.
  381. Trends and Disparities in U.S. Emergency Department Visits for Hypoglycemia, 1993–2005.

    24 February 2008

  382. Insulin-pump use in everyday practice: Data from an exhaustive regional registry in France.
  383. Observational Assessment of Family Functioning in Families with Children Who Have Type 1 Diabetes Mellitus.
  384. Methods for achieving stable normoglycemia during an educational camp for youth with type 1 diabetes mellitus.
  385. Missed opportunities-adolescents with a chronic condition (insulin-dependent diabetes mellitus) describe their cigarette-smoking trajectories and consider health risks.
  386. Insulin sensitivity in Type 1 diabetic children and adolescents.
  387. Occurence of thyroid autoimmunity in children with type 1 diabetes mellitus.
  388. A case of lipoatrophy with insulin detemir.
  389. Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens.
  390. Acute complications and drug-misuse are important causes of death for children and young adults with Type 1 diabetes: results from the Yorkshire Register of Diabetes in Children and Young People.
  391. Estimating Physician Effects on Glycemic Control in the Treatment of Diabetes: Methods, Effects Sizes, and Implications for Treatment Policy.

    17 February 2008

  392. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
  393. Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes.
  394. Hypoglycemia in Type 1 Diabetes - A still unresolved problem in the era of insulin analogs and pump therapy.
  395. The Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring.
  396. Short-term nocturnal hypoglycaemia increases morning food intake in healthy humans.
  397. Survey of glargine use in 115 pregnant women with Type 1 diabetes.
  398. The influence of pregnancy on progression of diabetic retinopathy.
  399. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
  400. Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State.
  401. Diabetes care in hospital—the impact of a dedicated inpatient care team.

    10 February 2008

  402. Attitudes, awareness and oral health-related quality of life in patients with diabetes.
  403. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects.

    3 February 2008

  404. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
  405. Use of CoZmonitor(R) in youth with type 1 diabetes.
  406. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
  407. Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress.
  408. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.
  409. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.
  410. ADA: Patients Beat Physicians at Insulin Dose Adjustment.
  411. The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus.
  412. Effective Treatment With Oral Sulfonylureas in Patients With Diabetes Due to Sulfonylurea Receptor 1 (SUR1) Mutations.
  413. Glycemic index of meals and postprandial glycemia in patients with permanent neonatal diabetes due to Kir6.2 gene mutations.
  414. Triple diabetes: coexistence of type 1 diabetes mellitus and a novel mutation in the gene responsible for MODY3 in an overweight adolescent.
  415. Peripheral neuropathy is an early complication of type 2 diabetes in adolescence.
  416. Small particle size of a solid meal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis.
  417. Insulin allergy: clinical manifestations and management strategies.

    27 January 2008

  418. Improved glycemic control in adolescents with type 1 diabetes mellitus who attend diabetes camp.
  419. High day-to-day glucose variability: A frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp.
  420. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus.
  421. Survey of glargine use in 115 pregnant women with Type 1 diabetes.
  422. Use of the NuvaRing(R) hormone-releasing system in late reproductive-age women with type 1 diabetes mellitus.
  423. Advanced glycation end products accumulate in the reproductive tract of men with diabetes.
  424. Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes. See also Diabetes Study Favors Surgery to Treat Obese and Bariatric Surgery Erases Type 2 Diabetes in Obese Patients.

    13 January 2008

  425. Impact of intensive insulin treatment on the development and consequences of oxidative stress in insulin-dependent diabetes mellitus.
  426. Can Serum beta-hydroxybutyrate Be Used To Diagnose Diabetic Ketoacidosis?.
  427. Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with type 1 diabetes: A multi-center, longitudinal survey in Germany and Austria.
  428. Impaired contractility and remodeling of the upper gastrointestinal tract in diabetes mellitus type-1.
  429. Physician Recommendations about Maternal Involvement in Adolescent Diabetes Management.
  430. The role of partner relationships in the young person's adherence to the diabetes self-care regime.
  431. Nail susceptibility to fungal infection in patients with type 1 and 2 diabetes under long term poor glycaemia control.

    6 January 2008

  432. Complications after body piercing in patient suffering from type 1 diabetes mellitus.
  433. Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients. Free full text available in HTML and PDF formats.
  434. Arterial Hypertension Determined By Ambulatory Blood Pressure Profiles: Contribution To Microalbuminuria Risk In A Multicenter Investigation In 2105 Children And Adolescents With Diabetes Mellitus Type 1.
  435. Rare complication of diabetic acidoketosis: the pneumomediastinum.

[ Current Daily Care News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:28:57
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.